基因疗法作为Scn2a突变诱导自闭症谱系障碍的新兴治疗方法
Arkadeep Ghosh1, Nitin Nadella1, A Paula Monaghan-Nichols1
1Department of Biomedical Sciences, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, United States.
Fundamental research
|December 30, 2024
概括
对自闭症谱系障碍 (ASD) 的基因治疗的研究重点是SCN2A基因. 克里斯普尔技术在治疗SCN2A功能丧失突变方面表现有前途,为治疗提供了新的治疗途径.
科学领域:
- 神经科学与遗传学
- 发育障碍 发育障碍 发展障碍
背景情况:
- 自闭症谱系障碍 (ASD) 是一种复杂的神经发育状况,病因不明确,没有确定的治疗方法.
- 遗传因素,特别是SCN2A基因的突变,越来越多地涉及到ASD病原体.
- SCN2A编码了NaV1.2通道,这对神经元功能至关重要.
研究的目的:
- 讨论SCN2A功能丧失 (LOF) 突变在ASD中的影响.
- 探索基因治疗的潜力,特别是基于CRISPR的方法,用于治疗SCN2A相关的ASD.
- 审查SCN2A LOF诱导的ASD现有的和新兴的治疗策略.
主要方法:
- 关于SCN2A突变及其与ASD的联系的科学文献的审查.
- 在SCN2A缺陷模型中讨论CRISPR-Cas9技术用于基因修复.
- 与新型基因疗法相比,分析当前的ASD治疗方法及其局限性.
主要成果:
- 在SCN2A中的功能丧失突变是ASD的重要遗传因素.
- 克里斯普尔技术为恢复SCN2A功能和潜在治疗SCN2A-LOFASD提供了一个有前途的工具.
- 现有的自闭症治疗方法有限,这凸显了对先进基因疗法的需求.
结论:
- 基因疗法,特别是使用CRISPR,对SCN2A相关的ASD具有潜在的突破性.
- 在ASD中成功临床应用基因疗法必须解决重要的生化和伦理问题.
- 需要进一步的研究来完善基因编辑技术,确保安全性和有效性.
相关概念视频
Gene Therapy
24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
What is Genetic Engineering?
72.7K
Overview
72.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K
Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
CRISPR
48.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.5K


